Characteristics of P2X7-like receptor activated by adenosine triphosphate in HIT-T15 cells

Pancreas

Volumn 35, Issue 1, 2007, Pages 53-62

  Lee, Dong Hyeon ^a   Kim, Eun Gi ^b   Park, Kyu Sang ^c   Jeong, Seong Woo ^c   Kong, In Deok ^c   Lee, Joong Woo ^b,c  

^a Korea Centers for Disease Control and Prevention   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Apoptosis; HIT T15 cell; Intracellular Ca2+ concentration; Inward current; P2X7 receptor; Permeability

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CALCIUM CHLORIDE; CALCIUM ION; DNA FRAGMENT; ETHIDIUM BROMIDE; MAGNESIUM ION; PURINE P2X7 RECEPTOR;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIPLOIDY; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; VOLTAGE CLAMP;

ADENOSINE TRIPHOSPHATE; AFFINITY LABELS; ANIMALS; APOPTOSIS; CALCIUM; CELL LINE; CELL MEMBRANE; CRICETINAE; DNA FRAGMENTATION; ETHIDIUM; FLOW CYTOMETRY; FLUORESCENT DYES; INSULIN-SECRETING CELLS; MAGNESIUM; MEMBRANE POTENTIALS; PERMEABILITY; RECEPTORS, PURINERGIC P2;

EID: 34250723355     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000278676.58491.ef     Document Type: Article

References (44)

1. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413-492.
2. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol. 2004;240:31-304.
3. Dubyak GR, el-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol. 1993;265:577-606.
4. Nuttle LC, Dubyak GR. Differential activation of cation channels and non-selective pores by macrophage P2Z purinergic receptors expressed in Xenopus oocytes. J Biol Chem. 1994;269:13988-13996.
5. 7). Science. 1996;272:735-738.
6. 7 receptor. Neuropharmacology. 1997;36:1277-1283.
7. Lee DH, Park KS, Kong ID, et al. Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines. BMC Immunol. 2006;7:22.
8. 2+-dependent plasminogen release from cultured microglia. Br J Pharmacol. 1998;123:1304-1310.
9. Grahames CB, Michel AD, Chessell IP, et al. Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br J Pharmacol. 1999;127:1915-1921.
10. Tokuyama Y, Hara M, Jones EM, et al. Cloning of rat and mouse P2Y purinoceptors. Biochem Biophys Res Commun. 1995;211:211-218.
11. Wang CZ, Namba N, Gonoi T, et al. Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. Biochem Biophys Res Commun. 1996;220:196-202.
12. Coutinho-Silva R, Parsons M, Robson T, et al. Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing. Cell Tissue Res. 2001;306:373-383.
13. Coutinho-Silva R, Parsons M, Robson T, et al. P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol Cell Endocrinol. 2003;204:141-154.
14. Petit P, Hillaire-Buys D, Manteghetti M, et al. Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell. Br J Pharmacol. 1998;125:1368-1374.
15. Fernandez-Alvarez J, Hillaire-Buys D, Loubatieres-Mariani MM, et al. P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas. 2001;22:69-71.
16. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
17. Rink TJ, Montecucco C, Hesketh TR, et al. Lymphocyte membrane potential assessed with fluorescent probes. Biochim Biophys Acta. 1980;595:15-30.
18. Bombeli T, Karsan A, Tait JF, et al. Apoptotic vascular endothelial cells become procoagulant. Blood. 1997;89:2429-2442.
19. Hockenbery D, Nunez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334-336.
20. 2+ influx by extracellular ATP in a pancreatic beta-cell line (HIT). Biochim Biophys Acta. 1989;1012:107-115.
21. Soltoff SP, McMillian MK, Talamo BR. ATP activates a cation-permeable pathway in rat parotid acinar cells. Am J Physiol. 1992;262:C934-C940.
22. el-Moatassim C, Dubyak GR. A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages. J Biol Chem. 1992;267:23664-23673.
23. Wiley JS, Chen JR, Snook MB, et al. The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP. Br J Pharmacol. 1994;112:946-950.
24. Murgia M, Hanau S, Pizzo P, et al. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J Biol Chem. 1993;268:8199-8203.
25. Cockcroft S, Gomperts BD. Activation and inhibition of calcium-dependent histamine secretion by ATP ions applied to rat mast cells. J Physiol. 1979;296:229-243.
26. Steinberg TH, Di Virgilio F. Cell-mediated cytotoxicity: ATP as an effector and the role of target cells. Curr Opin Immunol. 1991;3:71-75.
27. de Souza LR, Moore H, Raha S, et al. Purine and pyrimidine nucleotides activate distinct signaling pathways in PC12 cells. J Neurosci Res. 1995;41:753-763.
28. Ferrari D, Villalba M, Chiozzi P, et al. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol. 1996;156:1531-1539.
29. Pizzo P, Zanovello P, Bronte V, et al. Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel. Biochem J. 1991;274:139-144.
30. 7 receptor. J Physiol. 1999;519:335-346.
31. Steinberg TH, Newman AS, Swanson JA, et al. ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem. 1987;262:8884-8888.
32. Persechini PM, Bisaggio RC, Alves-Neto JL, et al. Extracellular ATP in the lymphohematopoietic system: P2Z purinoceptors off membrane permeabilization. Braz J Med Biol Res. 1998;31:25-34.
33. Coutinho-Silva R, Persechini PM. P2Z purinoceptor-associated pores induced by extracellular ATP in macrophages and J774 cells. Am J Physiol. 1997;273:C1793-C1800.
34. 7 receptor. EMBO J. 2006;25:5071-5082.
35. Ferrari D, Chiozzi P, Falzoni S, et al. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology. 1997;36:1295-1301.
36. Zanovello P, Bronte V, Rosato A, et al. Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. J Immunol. 1990;145:1545-1550.
37. Zoetewij JP, van de Water B, de Bont HJ, et al. The role of a purinergic P2z receptor in calcium-dependent cell killing of isolated rat hepatocytes by extracellular adenosine triphosphate. Hepatology. 1996;23:858-865.
38. 2+ increases plasma membrane permeability in murine macrophages. J Biol Chem. 1990;265:5635-5639.
39. i increase in differentiated neuroblastoma X glioma NG 108-15 cells. Neurosci Lett. 1999;264:97-100.
40. Fernando KC, Gargett CE, Wiley JS. Activation of the P2Z/P2X7 receptor in human lymphocytes produces a delayed permeability lesion: involvement of phospholipase D. Arch Biochem Biophys. 1999;362:197-202.
41. 7 agonists. Br J Pharmacol. 2000;129:703-708.
42. 7 purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol. 1997;121:1429-1437.
43. 7 purinoceptor by 17beta-oestradiol. J Physiol. 1998;508:659-666.
44. 7 purinoceptor expression in Xenopus oocytes is not sufficient to produce a pore-forming P2Z-like phenotype. FEBS Lett. 1997;411:339-345.